{"id":40316,"date":"2021-04-01T07:30:57","date_gmt":"2021-04-01T07:30:57","guid":{"rendered":"https:\/\/i-base.info\/htb\/?p=40316"},"modified":"2021-04-01T08:30:35","modified_gmt":"2021-04-01T08:30:35","slug":"bhiva-guidelines-on-covid-19-vaccines-and-people-living-with-hiv-draft-online-for-comment","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/40316","title":{"rendered":"BHIVA guidelines on COVID-19 vaccines and people living with HIV: DRAFT online for comment"},"content":{"rendered":"<div>\n<p class=\"HTBsubhead3authorcredit\"><strong><span lang=\"EN-US\">Simon Collins, HIV i-Base<\/span><\/strong><strong><span lang=\"EN-US\"><img loading=\"lazy\" decoding=\"async\" class=\" alignright\" src=\"https:\/\/i-base.info\/wp-content\/uploads\/2020\/03\/COVID-19-graphic.png\" width=\"231\" height=\"142\" \/><\/span><\/strong><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><strong><span lang=\"EN-US\">On 24 March 2021, the British HIV Association (BHIVA) posted draft guidelines on COVID-19 vaccinations in people living with HIV. The guidelines are online for comment for a month until 24 April 2021. [1]<\/span><\/strong><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><strong><span lang=\"EN-US\">A plain-language community summary will be posted online in the next week or so, at the same link. [1]<\/span><\/strong><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">The 17-page document reviews current evidence on the efficacy and safety of the main vaccines. It includes the following key recommendations.<\/span><\/p>\n<\/div>\n<div>\n<ul>\n<li class=\"HTBBODYindent\"><span lang=\"EN-US\">The increased risk of severe COVID-19 associated with HIV means that routine COVID-19 vaccination is strongly recommended for ALL people living with HIV.<\/span><\/li>\n<li class=\"HTBBODYindent\">There are no HIV-specific safety concerns for any of the mRNA, adenovirus or vector (protein) based vaccines. There are no concerns related to CD4 count or viral load.<\/li>\n<li class=\"HTBBODYindent\">The few contraindications (serious allergy to ingredients) are the same for people who are HIV positive and HIV negative.<\/li>\n<li class=\"HTBBODYindent\">The first vaccine offered is recommended: no vaccine is better than another.<\/li>\n<li class=\"HTBBODYindent\">Vaccinations are especially important for anyone with higher risks for COVID-19. These include:\n<ul>\n<li>HIV factors (low CD4 or detectable viral load).<\/li>\n<li>Non-HIV factors (other serious health issues).<\/li>\n<li>Pregnancy.<\/li>\n<\/ul>\n<\/li>\n<li class=\"HTBBODYindent\">It is important to complete the course (having both vaccine shots). The second vaccination should routinely be the same make, unless there was a severe reaction to the first shot. It the same vaccine is not available for any reason, a different vaccine can be used.<\/li>\n<li class=\"HTBBODYindent\">There is limited data on the duration of protection. Even if this if affected HIV a high degree of cover is still expected from all vaccines.<\/li>\n<li class=\"HTBBODYindent\">Further research will decide on whether future vaccine boosts are recommended. This includes in people living with HIV.<\/li>\n<li class=\"HTBBODYindent\">Vaccine protection should not be assumed. Future symptoms should still involve SARS-CoV-2 testing and speaking to a doctor.<\/li>\n<li class=\"HTBBODYindent\">Evaluating individual immune responses with antibody tests, either before or after vaccination, is not recommended, unless part of a research study.<\/li>\n<li class=\"HTBBODYindent\">Vaccines are recommended even if you recently had coronavirus. If symptoms are very recent, it is best to wait about four weeks before having the vaccine.<\/li>\n<li class=\"HTBBODYindent\">No recommendations are made for use of passive immunisation other that in a research setting.<\/li>\n<li class=\"HTBBODYindent\">As with HIV negative people, taking part in research studies is supported and recommended when appropriate.<\/li>\n<\/ul>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">Reference<\/span><\/p>\n<\/div>\n<div>\n<ol>\n<li class=\"HTBBODYtext\"><span lang=\"EN-US\">British HIV Association guidelines on immunisation for adults with HIV: SARS-CoV-2 (COVID-19) 2021 &#8211; consultation open. (24 March 2021).<br \/>\n<\/span><a href=\"https:\/\/www.bhiva.org\/COVID-19-immunisation-guidelines-consultation\">https:\/\/www.bhiva.org\/COVID-19-immunisation-guidelines-consultation<\/a> (webpage)<br \/>\n<a href=\"https:\/\/www.bhiva.org\/file\/605b1447c8ffa\/COVID-19-Immunisation-Guidelines-Consultation.pdf\">https:\/\/www.bhiva.org\/file\/605b1447c8ffa\/COVID-19-Immunisation-Guidelines-Consultation.pdf<\/a> (PDF link)<\/li>\n<\/ol>\n<\/div>\n<p><em>This report was first posted on 24 March 2021.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Simon Collins, HIV i-Base On 24 March 2021, the British HIV Association (BHIVA) posted draft guidelines on COVID-19 vaccinations in people living with HIV. The guidelines are online for comment for a month until 24 April 2021. [1] A plain-language &hellip;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[23,285,278],"tags":[],"class_list":["post-40316","post","type-post","status-publish","format-standard","hentry","category-guidelines","category-covid-19-guidelines","category-covid-19"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/40316","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=40316"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/40316\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=40316"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=40316"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=40316"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}